• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Funding Roundup

MiniMed expects to close $644M IPO next week ahead of Medtronic split

March 6, 2026 By Sean Whooley

Minimed

MiniMed has set the price for its planned initial public offering (IPO) ahead of an imminent separation from Medtronic (NYSE:MDT). The Medtronic Diabetes unit’s IPO includes 28 million shares of common stock priced at $20 apiece, amounting to $560 million. Underwriters also have an option to purchase up to 4.2 million additional shares at the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Initial Public Offering (IPO), Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic, minimed

Modular Medical prices $12M public offering to support insulin pump

March 4, 2026 By Sean Whooley

Modular Medical Logo (1)

Modular Medical (Nasdaq:MODD) announced the pricing of a public offering worth proceeds of approximately $12 million. San Diego-based Modular Medical’s offering includes nearly 68.1 million shares of the company’s common stock and warrants to purchase up to an aggregate of 68.1 million shares. The company priced the offering at $0.1762 per share and accompanying warrant. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Technology Tagged With: modularmedical

Trinity Biotech raises $25M as it looks to advance CGM+ system

February 25, 2026 By Sean Whooley

Trinity Biotech CGM+ slim

Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors Global provides the Dublin, Ireland-based company with additional funding to augment its commercialization initiatives and support its R&D programs. Under the SEPA, Trinity has the right, but not […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Trinity Biotech

Tandem Diabetes Care prices upsized $265M offering

February 25, 2026 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) today announced the pricing of a $265 million offering of convertible senior notes. San Diego-based Tandem earlier this week announced its intent to offer $200 million in notes, due 2032, in a private placement. It now says it upsized that offering by $65 million. The company also granted initial purchasers an […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Tandem Diabetes Care announces $200M notes offering

February 23, 2026 By Sean Whooley

Tandem Diabetes Care updated logo

This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here.   Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

CraniUS closes $20M financing to support blood-brain barrier tech for drug delivery

January 28, 2026 By Sean Whooley

CraniUS NeuroPass device blood brain barrier

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted drug delivery and monitoring in the brain. CraniUS has NeuroPass under development […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Neurological Tagged With: CraniUS

ViCentra closes $13M extension, brings Series D to $98M

January 8, 2026 By Sean Whooley

ViCentra Kaleido Blue worn on arm

Insulin patch pump maker ViCentra announced today that it closed a $13 million extension to its Series D financing round. Utrecht, The Netherlands-based ViCentra initially closed its Series D in September, bringing in $85 million. The now-closed extension to the financing brings the total raised to $98 million. CEO Tom Arnold explained the company’s plans […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Technology Tagged With: ViCentra

Enable Injections picks up $30M investment from Sanofi

January 6, 2026 By Sean Whooley

Enable Injections enFuse Empaveli Injector

Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth. The investment from the pharmaceutical giant aims to accelerate Enable’s manufacturing build-out. It follows the company’s 2024 announcement of plans to expand its Ohio manufacturing plant. Other uses for funds include strengthening supply chain capabilities and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Enable Injections, sanofi

Modular Medical prices $4.7M public offering

December 11, 2025 By Sean Whooley

Modular Medical Logo (1)

Modular Medical (Nasdaq:MODD) announced that it priced an underwritten public offering of common stock worth approximately $4.68 million. The San Diego-based insulin pump maker intends to offer nearly 12.2 million shares of common stock and accompanying warrants to purchase nearly 6.1 million shares. Each two-share package is being offered and sold together with one accompanying […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup Tagged With: modularmedical

1nhaler raises $2M for cardboard inhaler device

November 17, 2025 By Sean Whooley

The 1nhaler device - a single dose, dry powder inhaler 2025 (1)

1nhaler announced today that it secured approximately $2 million (£1.5 million) in seed funding to support its inhaler technology. The Scotland-based company develops a novel pop-up cardboard dry powder inhaler (DPI). Rather than use expensive, bulky plastic, 1nhaler uses cardboard to create an inhaler with the same dimensions as a credit card. The discreet platform […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup Tagged With: 1nhaler

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 47
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS